Insider Selling: Zoetis Inc. (NYSE:ZTS) EVP Sells 923 Shares of Stock

Zoetis Inc. (NYSE:ZTS) EVP Roxanne Lagano sold 923 shares of the business’s stock in a transaction on Thursday, April 18th. The shares were sold at an average price of $151.17, for a total transaction of $139,529.91. Following the sale, the executive vice president now owns 14,800 shares of the company’s stock, valued at approximately $2,237,316. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Roxanne Lagano also recently made the following trade(s):

• On Monday, March 18th, Roxanne Lagano sold 923 shares of Zoetis stock. The stock was sold at an average price of $173.33, for a total transaction of $159,983.59.
• On Monday, February 12th, Roxanne Lagano sold 363 shares of Zoetis stock. The stock was sold at an average price of $197.74, for a total transaction of $71,779.62.

Zoetis Stock Up 0.8 %

Shares of NYSE:ZTS traded up $1.17 on Thursday, hitting $153.11. 4,772,835 shares of the company traded hands, compared to its average volume of 2,989,420. Zoetis Inc. has a 52 week low of $148.48 and a 52 week high of $201.92. The company has a quick ratio of 2.00, a current ratio of 3.36 and a debt-to-equity ratio of 1.32. The stock has a 50 day simple moving average of $177.35 and a 200-day simple moving average of $180.39. The company has a market cap of $70.03 billion, a PE ratio of 30.15, a PEG ratio of 2.34 and a beta of 0.85.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Tuesday, February 13th. The company reported $1.24 earnings per share for the quarter, missing the consensus estimate of $1.32 by ($0.08). Zoetis had a net margin of 27.43% and a return on equity of 51.25%. The company had revenue of $2.21 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the previous year, the business earned $1.15 earnings per share. Zoetis’s revenue was up 8.5% compared to the same quarter last year. As a group, research analysts expect that Zoetis Inc. will post 5.79 earnings per share for the current year.

Zoetis Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 4th. Investors of record on Friday, April 19th will be issued a $0.432 dividend. The ex-dividend date is Thursday, April 18th. This represents a $1.73 annualized dividend and a yield of 1.13%. Zoetis’s payout ratio is 34.12%.

Analysts Set New Price Targets

Several research firms have commented on ZTS. StockNews.com downgraded shares of Zoetis from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Barclays upped their price target on Zoetis from $255.00 to $260.00 and gave the company an “overweight” rating in a research report on Wednesday, February 14th. Piper Sandler restated an “overweight” rating and issued a $195.00 price objective (down from $220.00) on shares of Zoetis in a research report on Tuesday. Stifel Nicolaus reduced their price target on shares of Zoetis from $215.00 to $195.00 and set a “buy” rating on the stock in a research report on Tuesday, April 2nd. Finally, The Goldman Sachs Group increased their price target on shares of Zoetis from $190.00 to $226.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Eight analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Zoetis presently has a consensus rating of “Buy” and a consensus target price of $221.75.

Institutional Investors Weigh In On Zoetis

Large investors have recently bought and sold shares of the business. Blue Bell Private Wealth Management LLC increased its holdings in Zoetis by 222.5% in the 4th quarter. Blue Bell Private Wealth Management LLC now owns 129 shares of the company’s stock worth $25,000 after buying an additional 89 shares in the last quarter. Evermay Wealth Management LLC increased its holdings in Zoetis by 439.3% in the 1st quarter. Evermay Wealth Management LLC now owns 151 shares of the company’s stock worth $25,000 after buying an additional 123 shares in the last quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC increased its holdings in Zoetis by 430.8% in the 1st quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 138 shares of the company’s stock worth $26,000 after buying an additional 112 shares in the last quarter. Worth Asset Management LLC bought a new stake in Zoetis in the 1st quarter worth about $26,000. Finally, Webster Bank N. A. grew its stake in shares of Zoetis by 89.1% during the 1st quarter. Webster Bank N. A. now owns 174 shares of the company’s stock valued at $29,000 after purchasing an additional 82 shares during the period. 92.80% of the stock is currently owned by institutional investors.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.